Cresco Labs (CRLBF) Shares Outstanding (Weighted Average) (2019 - 2026)

Cresco Labs has reported Shares Outstanding (Weighted Average) for 8 years, with the latest figure at $364.2 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding (Weighted Average) rose 3.99% year-over-year to $364.2 million; the trailing twelve-month figure through Mar 2026 stood at $364.2 million (up 3.99% YoY), and the FY2025 full-year result was $1.7 billion, up 0.91% from the prior year.
• Shares Outstanding (Weighted Average) for Q1 2026 stood at $364.2 million, down from $1.7 billion in the prior quarter.
• The five-year high for Shares Outstanding (Weighted Average) was $1.8 billion in Q3 2023, with the low at $301.1 million in Q3 2022.
• Historically, Shares Outstanding (Weighted Average) has averaged $1.1 billion across 5 years, with a median of $1.6 billion in 2022.
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) surged 1214291328.57% — and 2023, when it tumbled 81.55%.
• Cresco Labs' Shares Outstanding (Weighted Average) stood at $1.6 billion in 2022, then tumbled by 79.98% to $323.8 million in 2023, then surged by 427.09% to $1.7 billion in 2024, then increased by 0.91% to $1.7 billion in 2025, then slumped by 78.85% to $364.2 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $364.2 million (Q1 2026), $1.7 billion (Q4 2025), and $355.5 million (Q3 2025), per Business Quant data.